ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Oklahoma » Neurology

Top Neurology Prescribers in Oklahoma

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JOON-SHIK MOON MD

Neurology

169

$12.6K

25
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

0%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $242

CALIN PRODAN MD

Neurology

266

$29.8K

21
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 24%

$112
Average prescription price

Avg: $242

EDUARDO DE SOUSA M.D.

Neurology

295

$49.9K

50
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$169
Average prescription price

Avg: $242

CHERIAN KARUNAPUZHA MD

Neurology

344

$104K

44
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$303
Average prescription price

Avg: $242

BRETT DEES MD

Neurology

345

$19K

36
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $242

AMY STAUFFER M.D.

Neurology

478

$146K

60
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$305
Average prescription price

Avg: $242

ORD MITCHELL M.D.

Neurology

606

$62.2K

83
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 24%

$103
Average prescription price

Avg: $242

PEGGY WISDOM MD

Neurology

625

$216K

32
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$346
Average prescription price

Avg: $242

DARYL THOMPSON M.D.

Neurology

630

$94K

82
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$149
Average prescription price

Avg: $242

DAVID SMITH MD

Neurology

634

$238K

96
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 24%

$375
Average prescription price

Avg: $242

DAVID GORDON M.D.

Neurology

640

$25.6K

56
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $242

ANDREW GIN MD

Neurology

752

$90.8K

123
91 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$121
Average prescription price

Avg: $242

KERSI BHARUCHA MD

Neurology

780

$647K

97
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$829
Average prescription price

Avg: $242

JAMES COUCH MD,PHD

Neurology

804

$84K

65
26 are 65+

17%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

8%
prescriptions for brand name drugs

Avg: 24%

$105
Average prescription price

Avg: $242

FARHAT HUSAIN M.D.

Neurology

838

$1.54M

87
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

47%
prescriptions for brand name drugs

Avg: 24%

$1837
Average prescription price

Avg: $242

HAROLD GOLDMAN MD

Neurology

870

$76.2K

110
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

31%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

5%
prescriptions for brand name drugs

Avg: 24%

$88
Average prescription price

Avg: $242

DOUGLAS KAPLAN MD

Neurology

923

$150K

85
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 3%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$162
Average prescription price

Avg: $242

ROBERT TYNDALL M.D.

Neurology

937

$277K

91
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 24%

$295
Average prescription price

Avg: $242

MICHAEL MERKEY MD

Neurology

964

$137K

143
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 24%

$142
Average prescription price

Avg: $242

GABRIEL PITMAN D.O.

Neurology

1,016

$300K

142
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$296
Average prescription price

Avg: $242

ERNEST WARNER M.D.

Neurology

1,022

$296K

156
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

46%
prescriptions for brand name drugs

Avg: 24%

$289
Average prescription price

Avg: $242

MICHAEL KARATHANOS MD

Neurology

1,076

$180K

103
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 24%

$168
Average prescription price

Avg: $242

DEBORAH NILSON D.O.

Neurology

1,093

$65.6K

213
55 are 65+

59%
patients receiving schedule two controlled substances

Avg: 2%

64%
patients receiving schedule three controlled substances

Avg: 3%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $242

TEHSEEN KHAN MD

Neurology

1,122

$209K

123
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$187
Average prescription price

Avg: $242

LAWRENCE DAVIS MD

Neurology

1,127

$248K

121
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 24%

$220
Average prescription price

Avg: $242

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank